BHVN 250117 35.00C (BHVN250117C35000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BHVN250117C35000

Watchlist

4.50
0.000.00%

15min DelayClose Jan 3 16:00 ET

4.50High4.50Low

Intraday

5D
Daily

News

Biohaven Rises 6.1%
TipRanksDec 31, 2024 09:50 ET
Insider Purchase: Director at $BHVN (BHVN) Buys 29,000 Shares
Quiver QuantitativeDec 31, 2024 07:15 ET
Biohaven Insider Bought Shares Worth $1,042,393, According to a Recent SEC Filing
MT NewswiresDec 31, 2024 07:08 ET
H.C. Wainwright Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $59
Moomoo NewsDec 18, 2024 08:33 ET · Ratings
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved With BHV-1300, Gains Analyst Approval
BenzingaDec 17, 2024 14:23 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Biohavento Overweight
BenzingaDec 17, 2024 09:06 ET

Comments

Hashtags

Yesterday 04:41

$Biohaven (BHVN.US)$ bag a shit

NEWS

$Biohaven (BHVN.US)$
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
• Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) at 3 years in all study population genotypes.
◦ Troriluzole also showed statistically significant superiority after both 1 and 2 years of treatment.
• Tror...

Stock_Drift

Sep 22, 2024 07:57

$Biohaven (BHVN.US)$

Mr Long Term

Jul 24, 2024 18:48

Columns Top Calls on Wall Street | Nvidia, Tesla, Spotify, Apple, GM, Alphabet & More.

Here are Wednesday’s biggest calls on Wall Street:
RBC upgrades Estee Lauder $Estee Lauder (EL.US)$ to outperform from sector perform
RBC said it sees an attractive risk/reward.
“We are upgrading EL shares to Outperform. At this point, we believe EPS and investor sentiment have troughed and believe the risk-to-reward profile skews favorable.”
Morgan Stanley reiterates Tesla $Tesla (TSLA.US)$ as overweight
Morgan Sta...